SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PSDV - pSivida Limited
An SI Board Since November 2005
Posts SubjectMarks Bans Symbol
421 8 0 PSDV
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
396pSivida Corp. Announces UK’s NICE Says Yes to ILUVIEN® in Some Patients witJohn McCarthy-6/14/2013
395pSivida Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic DiabJohn McCarthy-4/2/2013
394Friday, November 30, 2012 pSivida partner to lower proposed price of Iluvien inJohn McCarthy-11/30/2012
393ALIM cc seekingalpha.com SEVERE EDIT We are on target to begin generating revJohn McCarthy-11/7/2012
392I posted this on Yahoo ..... $5,590,000,000 Market Opportunity11 second(s) ago John McCarthy-8/17/2012
391This is WEIRD. On the CC - ALIM expects the UK to approve Iluvien The pissing John McCarthy-8/17/2012
390Alimera’s Iluvien Fails To Win Backing From U.K. Cost Agency By Makiko KitamuraJohn McCarthy-8/8/2012
389pSivida Corp. Reports Alimera’s Intention to Resubmit Application to FDA for ILUJohn McCarthy-8/1/2012
388pSivida Corp. Announces Tech Evaluation Agreement for Tethadur™ Protein/AntibodyJohn McCarthy-7/30/2012
387Alimera Sciences' ILUVIEN® Receives Marketing Authorization in Germany John McCarthy-7/26/2012
386pSivida Corp. Announces United Kingdom Grants ILUVIEN® Marketing AuthorizaJohn McCarthy-5/7/2012
385Buyout speculation ..... SeekingAlpha SNIP I find the above information vJohn McCarthy-4/23/2012
384Psivida: Small-Cap Ophthalmology-Based BioTech Positioned For Long-Term Growth John McCarthy-4/18/2012
383Psivida Licensee Set For European Launch By Year's End April 11, 2012 byJohn McCarthy-4/11/2012
382Neuron is an investment of Johnson & Johnson Development Corporation andJohn McCarthy-3/13/2012
381pSivida Announces Second Tech Evaluation Agreement with its BioErodible DurasertJohn McCarthy-3/13/2012
3805:06PM Alimera Sciences entered into a manufacturing services agreement with FleJohn McCarthy-3/2/2012
379My post on Yahoo - PSDV Alimera Citi Presenation - Summary 1) $34 million inJohn McCarthy-2/29/2012
378Alimera Sciences Announces Positive Outcome to the European Decentralized ProcedJohn McCarthy-2/28/2012
377pSivida Corp. Announces Positive Outcome to European Decentralized Procedure forJohn McCarthy-2/28/2012
376 FDA Rejects Iluvien ========================= pSivida Reports Receipt by AlJohn McCarthy-11/11/2011
375WOW That is a very painful article to read. And makes me wonder about IOP resJohn McCarthy-11/9/2011
374GekkoWire has a good article on Iluvien "Alimera Sciences (ALIM) Iluvien PDtnsaf-11/8/2011
373This might sound disingenuous - but I think its very good news for Iluvien. (a)John McCarthy-9/1/2011
372msnbc.msn.com Don't know how this will impact PSDV, but it probably will raArthur Radley-9/1/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News